Clinical Trial Update: Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on targeted stem cells expressing TRAIL for lung cancer (adenocarcinoma of the lung) in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Lung Cancer

Drugs mentioned

• Targeted stem cells expressing TRAIL

Snippet

Sponsor: University College, London | Conditions: Adenocarcinoma of Lung | Phase 1, Phase 2 | Status: UNKNOWN